Abbott Labs Vs AbbVie: Which One Is The Best Investment Choice?

Summary:

  • Abbott Labs spun off AbbVie in 2013.
  • AbbVie has lost patent protection on its largest selling product Humira.
  • AbbVie has better financial metrics and dividends.
man adding a block showing the words Intellectual property on top of other wooden block with text copyright, patents, invention,and trademark

May Lim/iStock via Getty Images

Abbott Labs (ABT) and AbbVie (NYSE:ABBV) are two of the largest medical products companies in the world with an MV (Market Value) of $189 billion and $263 billion respectively. Both companies are based in the Chicago, IL suburbs.

From an


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


If you found this article to be of value, please scroll up and click the “Follow” button next to my name.

Note: members of my Turnaround Stock Advisory service receive my articles prior to publication, plus real-time updates.

Leave a Reply

Your email address will not be published. Required fields are marked *